Absci (ABSI) : 3-year performance

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs.

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 140
• Founded by Sean McClain in 2011 
• Headquartered in Vancouver, Washington
• https://www.absci.com

IPO: July 22, 2021; shares priced at $16

Ticker: ABSI